Elias Zambidis

Medicine & Life Sciences

1. Induced Pluripotent Stem Cells 100%
2. Human Embryonic Stem Cells 66%
3. Pluripotent Stem Cells 42%
4. Tankyrases 30%
5. Gaucher Disease 29%
6. Stem Cells 26%
7. Cyclophosphamide 24%
8. Hemangioblasts 23%
9. Bone Marrow Transplantation 22%
10. Haploidentical Transplantation 21%
11. Cardiac Myocytes 19%
12. Blood Vessels 18%
13. Epigenomics 17%
14. Yolk Sac 17%
15. B-Lymphocytes 17%
16. Graft vs Host Disease 16%
17. Embryoid Bodies 16%
18. Hematopoietic Stem Cells 15%
19. Hematopoiesis 14%
20. Hematologic Neoplasms 14%
21. Pediatrics 13%
22. Embryonic Stem Cells 13%
23. Transplantation 13%
24. Endothelial Cells 12%
25. Epitopes 11%
26. Tissue Donors 11%
27. Regenerative Medicine 11%
28. Immunoglobulin G 11%
29. Embryonic Structures 10%
30. Young Adult 10%
31. Fetal Blood 10%
32. Human Body 9%
33. Cellular Reprogramming 9%
34. Neoplasms 9%
35. Endothelium 8%
36. Immunoglobulins 8%
37. poly(ADP)-ribosylated proteins 8%
38. Genetic Therapy 8%
39. sphingosyl beta-glucoside 8%
40. Peptides 8%
41. Glucosylceramidase 7%
42. Macrophages 7%
43. Pericytes 7%
44. Leukemia Inhibitory Factor 7%
45. Transplants 7%
46. In Vitro Techniques 7%
47. interstitial retinol-binding protein 7%
48. Cell Line 6%
49. Bone Marrow 6%
50. Bone Marrow Failure Disorders 6%